During the past decade, Stamford Health conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stamford Health" #1 collaborator was "Massachusetts General Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Stamford Health" are "Diabetes Mellitus" (1 trials), "Irritable Bowel Syndrome Characterized by Constipation" (1 trials), "Lung Cancer" (1 trials), "NSCLC" (1 trials) and "Nodule Solitary Pulmonary" (1 trials). Many other conditions were trialed in "Stamford Health" in a lesser frequency.

Most popular intervention types in "Stamford Health" are "Drug" (5 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Placebo" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Blood Sample Collection" (1 trials) and "Botanical Tincture" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stamford Health" are 7 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Stamford Health". 1 are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Stamford Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Stamford Health, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".